Barbara Klencke

Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy

Howard A. Burris, Hope S. Rugo, Svetislava J. Vukelja et al. · Journal of Clinical Oncology · 2010 · 758 citations · Full text

Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101.

Barbara Klencke, Mark Matijevic, Robert G. Urban et al. · PubMed · 2002 · 230 citations

Vaccination, Mucosal Vaccination, High-grade Dysplasia +14

The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer

Rex Hoffman, Mark L. Welton, Barbara Klencke et al. · International Journal of Radiation Oncology*Biology*Physics · 1999 · 189 citations

Treatment And Prevention, Medicine, Human Retrovirus +12

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 164 citations

Hematological Malignancy, Bone Marrow Failure, Momelotinib Versus Danazol +6

High‐dose ¹³¹I‐metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma

Brian T. Rose, Katherine K. Matthay, David C. Price et al. · Cancer · 2003 · 157 citations · Full text